Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) shares gapped down prior to trading on Wednesday. The stock had previously closed at $4.08, but opened at $3.81. Anbio Biotechnology shares last traded at $3.97, with a volume of 1,856 shares trading hands.
Analyst Ratings Changes
Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, October 8th. One investment analyst has rated the stock with a Hold rating. According to data from MarketBeat, Anbio Biotechnology presently has a consensus rating of “Hold”.
Read Our Latest Report on Anbio Biotechnology
Anbio Biotechnology Price Performance
The firm’s 50-day moving average is $4.93 and its 200 day moving average is $16.27.
Anbio Biotechnology Company Profile
Anbio Biotechnology is a medical technology company focused on in vitro diagnostic products used to detect and monitor health conditions. Its offerings include diagnostic testing systems and related products designed for clinical and point-of-care settings. The company’s product portfolio includes testing equipment and diagnostic reagents, supporting the analysis of patient samples. These tools are intended to help healthcare providers obtain test results outside or alongside conventional laboratory workflows.
See Also
- Five stocks we like better than Anbio Biotechnology
- IonQ Raised the Bar, But 3 Quantum Rivals Face Tough Questions
- On Holding’s Sell-Off Overlooks a Key Part of Its Earnings Story
- Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI Demand
- Alphabet Escalates AI Chip Rivalry With NVIDIA
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
